Nasdaq · Healthcare
LifeMD, Inc. (LFMD)
As-reported financials and recent SEC filings for LifeMD, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$194.1M
Net income
$14.4M
Net margin
7.4%
Diluted EPS
$0.25
ROE
62.0%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $194.1M | $154.8M | $152.5M | $119.0M | $92.9M |
| Gross profit | $166.3M | $133.4M | $133.6M | $100.4M | $74.9M |
| Operating income | $-7.7M | $-20.4M | $-14.5M | $-43.4M | $-54.3M |
| Net income | $14.4M | $-21.4M | $-20.6M | $-45.5M | $-60.9M |
| Diluted EPS | $0.25 | $-0.60 | — | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-22
View on EDGAR →42026-06-03
View on EDGAR →32026-06-03
View on EDGAR →42026-05-13
View on EDGAR →10-Q2026-05-06
View on EDGAR →8-K2026-05-06
View on EDGAR →ARS2026-04-30
View on EDGAR →DEFA14A2026-04-30
View on EDGAR →Largest Healthcare peers
Go deeper on LFMD
Search LifeMD, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.